Ao Yu
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Nephrology top 10%
- Acute Kidney Injury Research
Papers in
-
- RNA Interference and Gene Delivery 4
- Polyamine Metabolism and Applications 3
- Advanced biosensing and bioanalysis techniques 2
- Oncology 5
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- David Oupický (13 shared papers)Weimin Tang (11 shared papers)Hang Yu (5 shared papers)Ying Xie (3 shared papers)Jing Li (3 shared papers)Ling Ding (9 shared papers)Rakesh K. Singh (2 shared papers)J. F. Bader (1 shared paper)
- Journals
- Journal of Controlled Release (2 papers)Molecular Pharmaceutics (1 paper)Bioactive Materials (1 paper)ACS Nano (1 paper)Biomacromolecules (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Ao Yu
16 papers receiving 384 citations
Peers
Comparison fields: 5 of 66
- Biomaterials 92
- Nephrology 38
- Cancer Research 56
- Oncology 82
- Molecular Biology 184
Countries citing papers authored by Ao Yu
This map shows the geographic impact of Ao Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ao Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ao Yu more than expected).
Fields of papers citing papers by Ao Yu
This network shows the impact of papers produced by Ao Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ao Yu. The network helps show where Ao Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ao Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 135 | |
| 2 | 2022 | 57 | |
| 3 | 2021 | 34 | |
| 4 | 2021 | 27 | |
| 5 | 2021 | 27 | |
| 6 | 2022 | 26 | |
| 7 | 2022 | 13 | |
| 8 | 2024 | 12 | |
| 9 | 2022 | 11 | |
| 10 | 2024 | 9 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 8 | |
| 13 | 2022 | 6 | |
| 14 | 2024 | 6 | |
| 15 | 2022 | 5 | |
| 16 | 2022 | 2 |
About Ao Yu
Ao Yu is a scholar working on Molecular Biology, Oncology, Surgery, Biomaterials and Cancer Research, having authored 16 papers that have together received 386 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Polyamine Metabolism and Applications (3 papers), Amino Acid Enzymes and Metabolism (2 papers), MicroRNA in disease regulation (2 papers), Acute Kidney Injury Research (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Biomaterials (92 citations), Nephrology (38 citations), Cancer Research (56 citations), Oncology (82 citations) and Molecular Biology (184 citations). Ao Yu has collaborated with scholars based in United States, China and Germany. Frequent co-authors include David Oupický, Weimin Tang, Hang Yu, Ying Xie, Jing Li, Ling Ding, Rakesh K. Singh, J. F. Bader, Dipakkumar R. Prajapati and Yazhe Wang. Their work appears in journals such as Journal of Controlled Release, Molecular Pharmaceutics, Bioactive Materials, ACS Nano and Biomacromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.